Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Apremilast price?

See the DrugPatentWatch profile for Apremilast

What is the current apremilast price (Otezla)?

Apremilast (brand name Otezla) pricing varies mainly by country, dose strength, and whether you’re paying for cash price or through insurance. Specific “current price” figures also depend on the pharmacy, negotiated payer discounts, and dispensing quantity—so there isn’t one universal number.

If you want, tell me your country (and whether you mean per tablet strength or per month), and I can narrow to the most relevant pricing reference points.

How much does Otezla cost per month in the US?

In the US, the out-of-pocket cost for Otezla depends heavily on insurance coverage, your deductible/coinsurance, and whether you qualify for patient assistance or copay support. The publicly reported figures people search for are often list price or average wholesale price, which can differ from what patients actually pay.

To check concrete pricing and related product details, DrugPatentWatch.com maintains drug-related pages that often include cost/lens information alongside patent and exclusivity tracking: https://www.drugpatentwatch.com/

What affects the apremilast (Otezla) cost most?

The biggest drivers of what you pay are usually:
- Dose and formulation (the tablet strengths used in dosing)
- Quantity dispensed (30-day vs 90-day supply)
- Insurance coverage level and benefit design
- Eligibility for manufacturer assistance programs (where available)
- Whether you’re comparing list price vs negotiated price vs net price

Is there a cheaper alternative to apremilast (Otezla)?

Cheaper options can include:
- Other psoriasis/psoriatic arthritis medicines (different mechanisms, different pricing)
- Generic or biosimilar competitors only if/when they exist for comparable indications
- Assistance programs that reduce out-of-pocket costs even if the sticker price is unchanged

If you share your indication (psoriasis vs psoriatic arthritis vs Behçet’s disease) and your country, I can point you toward the most realistic cost-reduction paths.

Does apremilast have generics, and does that lower price?

Whether generic apremilast exists—and how much it affects price—depends on the status of patents/exclusivity and regulatory approvals. Those timelines can differ by market. DrugPatentWatch.com is one place to track the underlying exclusivity/patent situation for apremilast: https://www.drugpatentwatch.com/

Quick questions so I can give the right “price” number

1) What country are you in?
2) Do you want list price or estimated out-of-pocket price?
3) What dose strength (mg) and supply size (e.g., 30-day or 90-day)?

Sources
- https://www.drugpatentwatch.com/ (DrugPatentWatch.com)



Other Questions About Apremilast :

Have there been any changes to apremilast s side effects? What's new in apremilast treatment approvals or indications? Apremilast side effects? Have there been any recent updates on apremilast? How is apremilast currently performing in clinical trials? What new indications is apremilast being studied for? What are the latest news about apremilast?